{"id":2581,"date":"2026-05-07T22:57:00","date_gmt":"2026-05-07T20:57:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=1f14d0d8d6a08bb6a736b01be123e3f3"},"modified":"2026-05-07T22:57:00","modified_gmt":"2026-05-07T20:57:00","slug":"securities-fraud-investigation-into-option-care-health-inc-opch-announced-shareholders-who-lost-money-urged-to-contact-glancy-prongay-wolke-rotter-llp-a-leading-securities-fraud-l","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=2581","title":{"rendered":"Securities Fraud Investigation Into Option Care Health, Inc. (OPCH) Announced \u2013 Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP<\/a>, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Option Care Health, Inc. (\u201cOption Care Health\u201d or the \u201cCompany\u201d) (NASDAQ: OPCH<\/a>) investors concerning the Company\u2019s possible violations of the federal securities laws.<\/p><\/a><\/a>

\nIF YOU ARE AN INVESTOR WHO LOST MONEY ON OPTION CARE HEALTH, INC. (OPCH), CLICK <\/b>HERE<\/b><\/a> TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.<\/b><\/p>

\nWhat Happened?\n<\/b>On April 30, 2026, Option Care Health released its first quarter 2026 financial results, including revenue of only $1.35 billion (a 1.3% increase year over year) missing consensus estimates, as well as net income of $45.3 million, down 3.0% year over year, and an adjusted EBITDA of $104.8 million, down 6.3% year over year. The Company also lowered its full year 2026 guidance for revenue by approximately $200 million at the mid-point.<\/p>

\nOn this news, Option Care Health\u2019s stock price fell $6.54, or 24.3%, to close at $20.33 per share on April 30, 2026, thereby injuring investors.<\/p>

\nContact Us To Participate or Learn More:\n<\/b>If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.\nCharles Linehan, Esq.,\nGlancy Prongay Wolke & Rotter LLP,\n1925 Century Park East, Suite 2100,\nLos Angeles California 90067\nEmail: shareholders@glancylaw.com<\/a>Telephone: 310-201-9150 (Toll-Free: 888-773-9224)\nVisit our website at www.glancylaw.com<\/a>.\nFollow us for updates on LinkedIn<\/a>, Twitter<\/a>, or Facebook<\/a>.<\/p>

\nWhistleblower Notice\n<\/b>Persons with non-public information regarding Option Care Health should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email shareholders@glancylaw.com<\/a>.<\/p>

\nAbout Glancy Prongay Wolke & Rotter LLP\n<\/b>GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm\u2019s recent successes, GPWR was named one of Law360\u2019s Securities Groups of the Year and ranked second-highest in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR\u2019s lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR\u2019s past successes have been widely covered by leading news and industry publications such as The Wall Street Journal<\/i>, The Financial Times<\/i>, Bloomberg Businessweek<\/i>, Reuters<\/i>, the Associated Press<\/i>, Barron\u2019s<\/i>, Investor\u2019s Business Daily<\/i>, Forbes<\/i>, and Money<\/i>. Prior results do not guarantee a similar outcome.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

\nGlancy Prongay Wolke & Rotter LLP,\n1925 Century Park East, Suite 2100,\nLos Angeles, CA 90067\nCharles Linehan<\/b>Email: shareholders@glancylaw.com<\/a>Telephone: 310-201-9150\nToll-Free: 888-773-9224\nVisit our website at: www.glancylaw.com<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Option Care Health, Inc. (\u201cOption Care Health\u201d or the \u201cCompany\u201d) (N…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2581","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/2581","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2581"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/2581\/revisions"}],"predecessor-version":[{"id":2582,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/2581\/revisions\/2582"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2581"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2581"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2581"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}